Research on Compound Nanxing Pain Paste for cold dampness arthralgia of rheumatic arthritis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10000963

Enrollment

Unknown

Registered

2010-07-03

Start date

2010-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Group A:Compound Nanxing Pain Paste

Group B:Pain-relieving plaster

Group C:Placebo

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age 40-70 years, male pr female; 2. Diagnosed as knee osteoarthritis; 3. Diagnosed as cold dampness arthralgia by traditional Chinese medicine; 4. VAS Score >=2; 5. With the informed consent signed.

Exclusion criteria

Exclusion criteria: 1. Complicated with severe cardiovascular, pulmonary, hepatic, renal hematopoietic disorders; 2. Arthralgia caused by other diseases: such as rheumatoid arthritis, ankylosing spondylitis, gout (onset); 3. Arthralgia resulted from other diseases: such as psoriasis, syphilopsychosis, ochronosis, metabolic bone disease, acute injury; 4. Accepted glucoticoid medication within 4 weeks; 5. Accepted non-steroidalanti-inflammatorydrugs medication within 2 weeks; 6. regnant or breast-feeding women or mental disorder; 7. Alleric to external applied paste; 8. Participating in other trials at the same time; 9. Other conditions are inproper for the trial.

Design outcomes

Primary

Measure	Time frame
VAS Score;	—

Countries

China

Contacts

Public ContactRongming Chen

crmnxyy@sina.com+86 13951028135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026